RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. NBank Capital
N

NBank Capital portfolio

NBank Capital has 3 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 3.
Deals, last 12 months: 2.
Rounds led: 2 of 3.
Capital in their rounds: $23.99M.
Latest deal: InhalPlus · Oct 26, 2026.
About this page

It led 2 of the 3 rounds it joined. Its most recent investment on record is InhalPlus's $559.4K Pre-seed round in October 2026, which it led. By category, its portfolio leans toward Health and bio (3) and Consumer and social (1). It has co-invested with Carma Fund, Life Science Valley Wachstumsfond and European Innovation Council Fund.

What NBank Capital invests in

NBank Capital recent investments

CompanyRoundDateAlongside
IInhalPlusPre-seed · $559.4K · leadnone named
AAllogeneticsSeed · $4.43M · leadLife Science Valley Wachstumsfond, Carma Fund
BBiowegSeries A · $19MAxeleo Capital (lead), Frank Jenner, BONVENTURE +1

How NBank Capital invests

StageDealsCapital in rounds
Series A 1 33%$19M
Seed 1 33%$4.43M
Pre-seed 1 33%$559.4K
YearDealsCapital in rounds
2025 1 33%$19M
2026 2 67%$4.99M

NBank Capital portfolio companies

CompanyRound with NBank CapitalTotal raisedLatest raise
IInhalPlus
Health and bio
Pre-seed · $559.4K · lead$559.4KOct 26, 2026
Pre-seed
AAllogenetics
Health and bio
Seed · $4.43M · lead$4.43MSep 9, 2026
Seed
BBioweg
Health and bio
Series A · $19M$19MSep 16, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 3 rounds on Recent Funding that name NBank Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists NBank Capital, which is a subset of its real portfolio. API: /api/v1/investors/nbank-capital (get a free API key). More: the most active VC firms and new venture capital funds.